FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Brown

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Physiology

Disease Progression

Procedures

Anatomy

Groin

Co-author Network

Publications

TOP 3
Kimberly B Higginbotham; Richard Lozano; Thomas Brown; Yehuda Z Patt; Takashi Arima; James L Abbruzzese; Melanie Thomas
A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma.
Melanie Thomas; Romil Chadha; Katrina Glover; Xuemei Wang; Jeffrey Morris; Thomas Brown; Asif Rashid; Janet Dancey; James L Abbruzzese
Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma.
Edward H Lin; Steven A Curley; Christopher C Crane; Barry W Feig; John M Skibber; Marc Delcos; Saroj-Raj Vadhan; Jeffrey Morris; Gregory D Ayers; Alicia Ross; Thomas Brown; Miguel A Rodriguez-Bigas; Nora Janjan
Retrospective study of capecitabine and celecoxib in metastatic colorectal cancer: potential benefits and COX-2 as the common mediator in pain, toxicities and survival?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Brown (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Kimberly B Higginbotham; Richard Lozano; Thomas Brown; Yehuda Z Patt; Takashi Arima; James L Abbruzzese; Melanie Thomas
A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma.
Journal of cancer research and clinical oncology 2008;134(12):1325-35.
2007: Melanie Thomas; Romil Chadha; Katrina Glover; Xuemei Wang; Jeffrey Morris; Thomas Brown; Asif Rashid; Janet Dancey; James L Abbruzzese
Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma.
Cancer 2007;110(5):1059-67.
2006: Edward H Lin; Steven A Curley; Christopher C Crane; Barry W Feig; John M Skibber; Marc Delcos; Saroj-Raj Vadhan; Jeffrey Morris; Gregory D Ayers; Alicia Ross; Thomas Brown; Miguel A Rodriguez-Bigas; Nora Janjan
Retrospective study of capecitabine and celecoxib in metastatic colorectal cancer: potential benefits and COX-2 as the common mediator in pain, toxicities and survival?
American journal of clinical oncology 2006;29(3):232-9.
2002: Christopher H Crane; Kenneth O Macdonald; Jean-Nicolas Vauthey; Patt Yehuda; Thomas Brown; Steven A Curley; Adrian Wong; Marc E Delclos; Chusilp Charnsangavej; Nora Janjan
Limitations of conventional doses of chemoradiation for unresectable biliary cancer.
International journal of radiation oncology, biology, physics 2002;53(4):969-74.
2001: Noah Taylor; Christopher Crane; John M Skibber; Barry W Feig; Lee Ellis; Jean-Nicolas Vauthey; S Hamilton; Karen Cleary; Ronelle A DuBrow; Thomas Brown; Robert Wolff; Paulo Hoff; NJ Sanfilippo; Nora Janjan
Elective groin irradiation is not indicated for patients with adenocarcinoma of the rectum extending to the anal canal.
International journal of radiation oncology, biology, physics 2001;51(3):741-7.
2001: Nora Janjan; Christopher Crane; Barry W Feig; Karen Cleary; Ronelle A DuBrow; Steven A Curley; Jean-Nicolas Vauthey; P Lynch; Lee M Ellis; Robert Wolff; Renato Lenzi; James L Abbruzzese; Richard Pazdur; Paulo M Hoff; Pamela Allen; Thomas Brown; John M Skibber
Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer.
American journal of clinical oncology 2001;24(2):107-12.
2000: Nora Janjan; C N Crane; Barry W Feig; Karen Cleary; Ronelle A DuBrow; Steven A Curley; Lee M Ellis; Jean-Nicolas Vauthey; Renato Lenzi; P Lynch; Robert Wolff; Thomas Brown; Richard Pazdur; James L Abbruzzese; Paulo M Hoff; Pamela Allen; B Brown; John M Skibber
Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer.
International journal of radiation oncology, biology, physics 2000;47(3):713-8.